PD-1 inhibitor combined with radiotherapy and GM-CSF in MSS/pMMR metastatic colon cancer: a case report

Patients with chemo-refractory metastatic colorectal cancer (mCRC) have poor prognoses. The application of programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) inhibitors encouragingly improved the survival of mCRC patients with microsatellite instability-high (MSI-H)/mismat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jiabao, Xing, Pengfei, Kong, Yuehong, Xu, Meiling, Zhang, Liyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176449/
https://www.ncbi.nlm.nih.gov/pubmed/37188188
http://dx.doi.org/10.3389/fonc.2023.1078915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176449/
https://www.ncbi.nlm.nih.gov/pubmed/37188188
http://dx.doi.org/10.3389/fonc.2023.1078915

Ejemplares similares